Acutus Medical Stock Performance
| AFIB Stock | USD 0.0002 0.00 0.00% |
Acutus Medical holds a performance score of 21 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 6.08, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Acutus Medical will likely underperform. Use Acutus Medical value at risk and the relationship between the skewness and day typical price , to analyze future returns on Acutus Medical.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Acutus Medical are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady forward indicators, Acutus Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Acutus |
Acutus Medical Relative Risk vs. Return Landscape
If you would invest 0.05 in Acutus Medical on October 19, 2025 and sell it today you would lose (0.03) from holding Acutus Medical or give up 60.0% of portfolio value over 90 days. Acutus Medical is currently generating 67.8102% in daily expected returns and assumes 253.4978% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Acutus, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Acutus Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acutus Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Acutus Medical, and traders can use it to determine the average amount a Acutus Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2675
| High Returns | Best Equity | AFIB | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Acutus Medical is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acutus Medical by adding it to a well-diversified portfolio.
Acutus Medical Fundamentals Growth
Acutus Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Acutus Medical, and Acutus Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Acutus Pink Sheet performance.
| Return On Equity | -0.32 | |||
| Return On Asset | -0.14 | |||
| Operating Margin | (2.89) % | |||
| Current Valuation | 18.75 M | |||
| Shares Outstanding | 29.72 M | |||
| Price To Book | 0.53 X | |||
| Price To Sales | 0.73 X | |||
| Revenue | 7.16 M | |||
| EBITDA | (13.49 M) | |||
| Cash And Equivalents | 88.97 M | |||
| Cash Per Share | 3.14 X | |||
| Total Debt | 38.48 M | |||
| Debt To Equity | 0.51 % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (63.61 M) | |||
| Earnings Per Share | (0.41) X | |||
| Total Asset | 53.96 M | |||
| Retained Earnings | (599.98 M) | |||
About Acutus Medical Performance
By analyzing Acutus Medical's fundamental ratios, stakeholders can gain valuable insights into Acutus Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Acutus Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Acutus Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California. Acutus Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 338 people.Things to note about Acutus Medical performance evaluation
Checking the ongoing alerts about Acutus Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Acutus Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Acutus Medical is way too risky over 90 days horizon | |
| Acutus Medical has some characteristics of a very speculative penny stock | |
| Acutus Medical appears to be risky and price may revert if volatility continues | |
| Acutus Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 7.16 M. Net Loss for the year was (11.92 M) with loss before overhead, payroll, taxes, and interest of (15.55 M). | |
| Acutus Medical currently holds about 88.97 M in cash with (63.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from simplywall.st: Kosmos Energy Valuation After Operational Progress In Ghana And GTA LNG Plus New Bond Offering |
- Analyzing Acutus Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Acutus Medical's stock is overvalued or undervalued compared to its peers.
- Examining Acutus Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Acutus Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Acutus Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Acutus Medical's pink sheet. These opinions can provide insight into Acutus Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Acutus Pink Sheet analysis
When running Acutus Medical's price analysis, check to measure Acutus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acutus Medical is operating at the current time. Most of Acutus Medical's value examination focuses on studying past and present price action to predict the probability of Acutus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acutus Medical's price. Additionally, you may evaluate how the addition of Acutus Medical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |